CDKN2A and angiosarcoma: A recent study analyzed tumors from animals overexpressing mutated Cdk4 or Cdk6, which severely impairs the function of all four Cdkn2 cell cycle regulators but not of p19ARF [199, 200], and found that 56% of all tumors in these animals were angiosarcomas [122, 161].